Stocklytics Platform
Asset logo for symbol KALV
KalVista Pharmaceuticals
KALV52
$11.54arrow_drop_up2.21%$0.25
Asset logo for symbol KALV
KALV52

$11.54

arrow_drop_up2.21%

AI Deep-Learning Forecast (KALV)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

KalVista Pharmaceuticals (KALV) Stocklytics Forecast

According to the stock price prediction models and forecasts, KalVista Pharmaceuticals Inc (KALV) is expected to experience positive growth in the coming years. Analysts believe that the stock price of KALV will continue to rise steadily, making it a potentially profitable investment. The machine learning algorithms suggest that KALV has the potential to perform well in the market. The AI predicts that KALV stock will show an upward trend in the future.
Furthermore, analysts have provided a price target for KalVista Pharmaceuticals Inc (KALV) stock, estimating its potential value in the year 2023. The price target indicates the projected stock price that analysts believe KALV will reach by that time. This target may serve as a reference point for investors to make informed decisions. Analyst ratings for KALV stock are generally positive, indicating that it is a good buy. Investors may consider the positive analyst ratings and price target when evaluating the investment potential of KalVista Pharmaceuticals Inc (KALV).
add KalVista Pharmaceuticals  to watchlist

Keep an eye on KalVista Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for KalVista Pharmaceuticals (KALV) stock?

Analysts have set a target price of $31.76 for KalVista Pharmaceuticals (KALV), based on forecasts from 21 analysts. The predicted price range extends from a high of $55 to a low of $16. This represents a potential increase of up to 376.4% and a decrease of 38.59% from the current price of $11.54. These forecasts are as of 2017 Oct 16.
help

What are the analyst ratings for KalVista Pharmaceuticals (KALV) stock?

The analyst ratings for KalVista Pharmaceuticals (KALV) are distributed as follows: 1 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering KalVista Pharmaceuticals .
help

What is the AI price prediction for KalVista Pharmaceuticals (KALV) stock?

At present, there is no AI or machine-learning-based price prediction available for KalVista Pharmaceuticals (KALV) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media